Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Stem cells (Dayton, Ohio) - 1 Oct 2008

Yamada Satsuki, Nelson Timothy J, Crespo-Diaz Ruben J, Perez-Terzic Carmen, Liu Xiao-Ke, Miki Takashi, Seino Susumu, Behfar Atta, Terzic Andre

Abstract excerpt

Pathogenic causes underlying nonischemic cardiomyopathies are increasingly being resolved, yet repair therapies for these commonly heritable forms of heart failure are lacking. A case in point is human dilated cardiomyopathy 10 (CMD10; Online Mendelian Inheritance in Man #608569), a progressive organ dysfunction syndrome refractory to conventional therapies and linked to mutations in cardiac ATP-sensitive K(+)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomegaly
Share to Cell- and Tissue-Based Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Conduction System

Share to Heart Function Tests

Share to KATP Channels

Share to Myocardial Contraction

Share to Stem Cell Transplantation

Share to Ventricular Remodeling

Source

Open in PubMed Open full text

Identifiers

PMID: 18669912
DOI: 10.1634/stemcells.2008-0187
PMCID: PMC2743410

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.PMID 18669912Read ↗

Induced Pluripotent Stem Cells: A New Dawn for the Treatment of Ischemic CardiomyopathySemantic proximity Read ↗

Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.Semantic proximity Read ↗

Targeted Therapies in Genetic Dilated and Hypertrophic Cardiomyopathies: From Molecular Mechanisms to Therapeutic Targets. A Position Paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Semantic proximity Read ↗

Investigating Inherited Heart Diseases Using Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.Semantic proximity Read ↗

Elucidating arrhythmogenic right ventricular cardiomyopathy with stem cells.Semantic proximity Read ↗

Cardiac stem cellsSemantic proximity Read ↗

Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic CardiomyopathiesSemantic proximity Read ↗

Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and ChallengesSemantic proximity Read ↗

Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes.Semantic proximity Read ↗

Cardiac Regenerative MedicineSemantic proximity Read ↗

The march of pluripotent stem cells in cardiovascular regenerative medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.